The Chemical Inhibitory Effect of G9a Enzyme on Decrease of Proliferative Potential and Increase of the Adipogenic Propensity of Mesenchymal Stem Cells

Subject Areas : Journal of Animal Biology

Hedyeh Khanban ¹ , Esmaeil Fattahi ² , Mahmoud Talkhabi ³

1 - Department of Biology, Ayatollah Amoli Branch, Islamic Azad University, Amol, Iran
2 - Department of Biology, Ayatollah Amoli Branch, Islamic Azad University, Amol, Iran
3 - Department of Animal Sciences and Biotechnology, Faculty of Biological Sciences and Technology, Shahid Beheshti University, Tehran, Iran

Received: 2019-08-26 Accepted : 2020-03-15 Published : 2020-06-20

Keywords: Mesenchymal stem cells, Epigenetic, Adipogenesis, A366, G9a,

Abstract :

Mesenchymal stem cells (MSCs) have unique properteis such as immunomodulatory function, secretion of cell survival factors, and the potential of bone , cartilage, and fat differentiation. All of the cellular processes including differentiation, proliferation, aging, and cell death are directly or indirectly regulated by epigenetic mechanisms such as histone methylation. G9a histone methyltransferase is one of the most important enzymes controlling cell behaviors. MSCs were isolated from rat bone marrow (BM-MSCs) and cultured in vitro. Bone marrow-derived MSCs (BM-MSCs) were treated with different doses of A366 (a specific G9a inhibtior) at the passages 1-3 of the primary culture. Then the proliferative capacity of BM-MSCs was analyzed using flowcytometry, assessment of the cell population doubling time, and studying the cell-cycle profile. The rate of adipogenic differentiation of A366-treated BM-MSCs was evaluated using oil red staining and fat gene expression analysis. Assessment of the PDT of BM-MSCs and cell-cycle profile showed that inhibition of G9a using low concentrations of A366 didn’t have any significant effect on BM-MSCs proliferative potential. However, the high doses of A366 increased the PDT and induced cell-cycle arrest. Moreover, A366 increased the adipogenic potential of BM-MSCs. Epigenetic regulators such as A366 that have been suggested for controlling cancers can affect BM-MSCs proliferative and differentiation behaviors. These regulators might also be used as a strategy for a more efficient proliferation and differentiation of MSCs to be used in cell therapy, tissue engineering, regeneration and tissue homeostasis.

References:

1. Ahn M.J., Jeong S.G., CHO G.W. 2016. Antisenescence activity of G9a inhibitor BIX01294 on human bone marrow mesenchymal stromal cells. Turkish Journal of Biology, 40(2): 443-451.


2. Ding, D. C.,. Shyu W.C., Lin S.Z., 2011. Mesenchymal stem cells. Cell Transplantation, 20(1): 5-14.


3. Dominici M.,  Blanc K., Mueller I. 2006. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy, 8(4): 315-317.


4. Duncan  E.J., Gluckman P.D., Dearden P.K. 2014. Epigenetics, plasticity, and evolution: How do we link epigenetic change to phenotype? Journal of Experimental Zoology Part B: Molecular and Developmental Evolution, 322(4): 208-220.


5. Eisenberg C.A., Eisenberg L.M. 2019. G9a and G9a-Like Histone Methyl transferases and Their Effect on Cell Phenotype, Embryonic Development, and Human Disease, in The DNA, RNA, and Histone Methylomes. Springer, 23: 399-433.


6. Eslaminejad B.M., Talkhabi M., Zeynali B. 2008. Effect of Lithium chloride on proliferation and bone differentiation of rat marrow-derived mesenchymal stem cells in culture. Iranian Journal of Basic Medical Sciences, 11(3): 143-151.


7. Fabrizio P., Garvis S., F. Palladino F., 2019.  Histone methylation and memory of environmental stress. Cells, 8(4): 339-346.


8. Husmann D., Gozani O., 2019. Histone lysine methyltransferases in biology and disease. Nature Structural and Molecular Biology, 26(10): 880-889.


9. Khanban H., Fattahi E., Talkhabi M., 2019. In vivo administration of G9a inhibitor A366 decreases osteogenic potential of bone marrow-derived mesenchymal stem cells. Excli journal, 18: 300-308.


10. Liu N., 2015. Recognition of H3K9 methylation by GLP is required for efficient establishment of H3K9 methylation, rapid target gene repression, and mouse viability. Genes and Development, 29(4): 393-379.


11. Nicetto D., Zaret K.S. 2019. Role of H3K9me3 heterochromatin in cell identity establishment and maintenance. Current Opinion in Genetics and Development, 55: 1-10.


12. Pappano W.N., Guo J., He Y., Ferguson D. 2015. The histone methyltransferase inhibitor A-366 uncovers a role for G9a/GLP in the epigenetics of leukemia. PloS One, 10(7): 12: 34-49.


13. Purcell D.J., 2012. Recruitment of coregulator G9a by Runx2 for selective enhancement or suppression of transcription. Journal of Cellular Biochemistry, 113(7): 2406-2414.


14. Wang M., Yuan Q., Xie L. 2018.  Mesenchymal stem cell-based immunomodulation: properties and clinical application. Stem cells International, 2(5): 67-78.